The following is a summary of “Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid ...

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...

For instance, the transcription factor ARID3A has been shown to suppress leukemia pathogenesis by promoting ... which differs from other types of acute myeloid leukemia[4]. This includes the ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

ALL = Acute lymphoblastic leukemia; AML = Acute myeloid leukemia; FTI = Farnesyltransferase inhibitor; HDAC = Histone deacetylase; NF = Nuclear factor; Ph = Philadelphia chromosome; TKI = Tyrosine ...

TBI remained significantly associated with reduced adjusted risks of grade 3 to 4 aGVHD and moderate-severe cGVHD.

MDS can also progress to Acute Myeloid Leukemia (AML), which is a more ... The role of the immune system in the pathophysiology of MDS is firmly established. However, routine immune monitoring ...

The Kharas lab aims to uncover novel RNA regulators in stem cell biology and development in hopes of improving our understanding of cancer pathogenesis and treatment ... with a worse clinical outcome ...